IGF-1 LR3 1MG

IGF-1 LR3 is a modified peptide variant derived from insulin-like growth factor 1 (IGF-1), specifically designed to enhance bioavailability and stability in biological systems. This peptide is commonly utilized in academic and industrial research settings for studies investigating growth factor signaling, cellular differentiation, and regenerative biology. Its structure, characterized by substitutions at specific amino acid positions, enables prolonged activity and reduced immunogenicity compared to native IGF-1, making it valuable for research applications.

Research Context

IGF-1 LR3 has been extensively studied as a research tool due to its distinct biochemical properties. Originally developed for its therapeutic potential in promoting tissue regeneration and anti-aging effects, its research applications now span various scientific disciplines. Investigators often employ IGF-1 LR3 to model cellular responses to growth factors, study its role in tissue repair, or evaluate its interactions with receptor pathways in vitro and in vivo.

Research Overview

IGF-1 LR3 is engineered to mitigate the rapid clearance of IGF-1 from circulation, allowing for prolonged exposure to target cells. The substitutions—particularly at the C-terminal—prevent cleavage by proteases, extending its half-life and enhancing its utility in studies requiring sustained presence in biological matrices. This variant is frequently used in preclinical research to assess the effects of growth factors on tissue regeneration, metabolic processes, and developmental biology under controlled conditions.

Key Research Focus Areas

• Tissue Regeneration: IGF-1 LR3 is investigated for its potential in regenerative medicine, including studies on wound healing, muscle repair, and organ regeneration.
• Cellular Differentiation: Researchers employ this peptide to study how IGF-1 influences the commitment of stem cells to specific lineages, including neuronal, muscle, or adipogenic pathways.
• Anti-Aging Mechanisms: Preclinical research explores IGF-1 LR3’s role in delaying age-related decline in tissues, particularly in models of senescence.
• Receptor Signaling Pathways: Investigations focus on its interaction with IGF-1 receptors (IGF-1R) and downstream signaling cascades, such as the PI3K/Akt pathway, to understand regulatory dynamics.
• Metabolic Studies: IGF-1 LR3 is used to elucidate its effects on glucose metabolism, lipid homeostasis, and insulin sensitivity in various experimental systems.

Safety and Compliance

As a research-use-only product, IGF-1 LR3 is not intended for human or animal consumption. It must be handled with sterile techniques and disposed of according to laboratory protocols to ensure compliance with biosafety standards. Users are advised to follow established institutional guidelines for storage, handling, and disposal of peptide research materials to mitigate potential risks. Always conduct experiments within a controlled research environment under the supervision of qualified personnel.

For research use only. Not for human or animal consumption.

All claims and applications are for educational and investigational purposes only.